DisGeNET - a database of gene-disease associations

response to simvastatin, C3894553

Source: ALL

Results per page

Gene

Disease

Variant

Source

Association Type

Semantic type

Protein Class

Disease Class

Type

Original DB

Consequence

DSI _v

DPI _v

pLI

EI _vda

EL _gda

Score _vda

PMID

PMID Year

AF_EXOME

Num. PMIDs

Num. SNPs_gda

AF_GENOME

Variant

Gene

Risk Allele

Score _vda

Association Type

Original DB

Sentence supporting the association

PMID

PMID Year

dbSNP:

rs4988198

MCM6

0.700

GeneticVariation

GWASCAT

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

28736931

2018

dbSNP:

rs73354145

MRPL12

0.700

GeneticVariation

GWASCAT

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

28736931

2018

dbSNP:

rs115092681

NLGN1

0.700

GeneticVariation

GWASCAT

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

28736931

2018

dbSNP:

rs141864436

NRXN1

0.700

GeneticVariation

GWASCAT

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

28736931

2018

dbSNP:

rs57504626

PBX4

0.700

GeneticVariation

GWASCAT

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

28736931

2018

dbSNP:

rs112284299

PEX5L

0.700

GeneticVariation

GWASCAT

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

28736931

2018

dbSNP:

rs6693796

PRRX1

0.700

GeneticVariation

GWASCAT

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

28736931

2018

dbSNP:

rs143838781

RBM19

0.700

GeneticVariation

GWASCAT

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

28736931

2018

dbSNP:

rs75639901

SCGN

0.700

GeneticVariation

GWASCAT

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

28736931

2018

dbSNP:

rs2631781

ST6GALNAC3

0.700

GeneticVariation

GWASCAT

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

28736931

2018

dbSNP:

rs58847779

TRIOBP

0.700

GeneticVariation

GWASCAT

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

28736931

2018

dbSNP:

rs7810240

ZNF775

0.700

GeneticVariation

GWASCAT

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

28736931

2018